Every process people chase for longevity — strength, cognition, metabolic health, recovery — runs on cellular energy. That energy comes from your mitochondria. When they decline, so does almost everything else. This is a plain-English, evidence-graded guide to keeping them healthy.
*Mitochondrial turnover varies widely by tissue — days in some, weeks in others. You are constantly rebuilding them, which is why intervention works.
Forget "the powerhouse of the cell." Mitochondria are better understood as the cell's metabolic decision-makers — they don't just make energy, they sense the environment and decide how the cell responds.
Through the electron transport chain and oxidative phosphorylation, mitochondria convert food and oxygen into ATP — the energy currency every cell spends to function.
They regulate calcium, generate signalling molecules, and release peptides (like MOTS-c and humanin) that talk to the rest of the body about metabolic state.
Mitochondria trigger apoptosis — programmed cell death. Dysfunctional ones can drive inflammation, senescence, and the removal (or survival) of damaged cells.
A mitochondrion is a specialised structure inside nearly every cell that burns fuel with oxygen to produce ATP. It carries its own small genome (mtDNA, 37 genes), reproduces by splitting, and lives in a constantly reshaping network — fusing, dividing, and being recycled. Healthy tissue keeps this network dense, efficient, and clean. Aging tissue does the opposite.
Mitochondrial dysfunction is one of the twelve hallmarks of aging defined by López-Otín and colleagues (2023). Decline isn't one failure — it's several reinforcing ones.
Mitochondrial DNA sits right next to the electron transport chain — a source of reactive oxygen species — and has weaker repair machinery than nuclear DNA. Mutations and deletions build up over decades, degrading the proteins the mitochondria need to make energy.
The master regulator PGC-1α drives the creation of new mitochondria. Its signalling declines with age and inactivity, so the body builds fewer fresh mitochondria to replace worn-out ones.
Mitophagy is the quality-control process that identifies and recycles damaged mitochondria. As it slows with age, defective mitochondria linger, leak ROS, and drag down the whole network.
NAD+ is an essential coenzyme for energy metabolism and for the sirtuin enzymes that maintain mitochondria. Tissue NAD+ declines substantially with age, throttling the machinery that keeps mitochondria running.
The inner membrane lipid cardiolipin organises the electron transport chain. Oxidative damage to cardiolipin disrupts energy production and destabilises the membrane — a specific target of the peptide elamipretide.
Damaged mitochondria leak mtDNA into the cell, which the immune system reads as a danger signal — feeding chronic, low-grade inflammation ("inflammaging") that accelerates other hallmarks of aging.
It's the most connected node in the network — but honesty matters here, because the science is more nuanced than the marketing.
Mitochondrial dysfunction sits at the centre of aging because it interacts with almost every other hallmark. Failing mitochondria drive genomic instability (ROS damage to DNA), cellular senescence, chronic inflammation, stem-cell exhaustion, and impaired nutrient sensing. Fix mitochondrial function and you often improve several hallmarks at once — which is exactly why longevity research keeps returning to bioenergetics.
But mitochondria are also downstream of those same processes — DNA damage, telomere loss, and lost proteostasis all degrade mitochondria in turn. The most defensible view from the current literature is that mitochondrial dysfunction is both a cause and a consequence of aging: a central hub in a web of reinforcing failures, not a single master switch. That's still the best reason to prioritise it — improving mitochondrial health is one of the highest-leverage things you can do for healthspan, even if calling it "the root cause" overstates the science.
Because energy is required for every repair and maintenance process — DNA repair, protein folding, autophagy, immune surveillance — a cell with failing mitochondria can't maintain itself well no matter how good its other machinery is. Energy is the budget the rest of the cell spends. That's the practical case for treating mitochondrial health as a foundation rather than an afterthought.
No supplement or peptide comes close to what training and metabolic stress do for mitochondria. This is the part that actually works — start here.
Sustained moderate-intensity cardio is the classic driver of mitochondrial biogenesis via AMPK — PGC-1α. Evidence is strongest for longer sessions (45–90 min). Aim for 150+ min/week. Note: recent reviews argue the mitochondrial edge of Zone 2 specifically is modest and duration-dependent — total volume matters more than hitting an exact heart-rate zone.
Short, hard intervals produce strong biogenesis signalling and improve mitochondrial quality and VO₂max efficiently. Best used alongside aerobic base work, not instead of it. 1–2 sessions/week is plenty.
Preserves muscle mass — the body's largest reservoir of mitochondria — and protects metabolic health and NAD+ demand with age. 2–3 sessions/week.
Mitochondrial repair, mitophagy, and metabolic reset are sleep-dependent. Chronic short sleep measurably impairs mitochondrial function. 7–9 hours; protect it before optimising anything else.
Avoiding chronic energy surplus, prioritising protein and polyphenol-rich whole foods, and not eating in a constant fed state all support mitochondrial efficiency. Time-restricted eating and periodic fasting can stimulate mitophagy — human data are promising but less definitive than the exercise evidence.
Repeated sauna use activates heat-shock proteins and is associated in observational data with lower cardiovascular and all-cause mortality. Plausible mitochondrial and vascular benefits; causal data are still limited.
Cold can activate brown fat and may nudge biogenesis and mitochondrial uncoupling. Mechanistically interesting, human longevity evidence thin — a reasonable extra, not a foundation.
Supplements are additive to lifestyle, never a replacement. Graded by strength of human evidence for mitochondrial or healthspan-relevant outcomes — not by hype.
| Compound | What it does | Human evidence | Grade |
|---|---|---|---|
Urolithin A (Mitopure) | Postbiotic that induces mitophagy — clears damaged mitochondria. | Multiple placebo-controlled RCTs show modest but real gains in muscle strength (~12%) and endurance at ~500–1000 mg/day, including in older adults. | Grade B |
Creatine | Buffers cellular energy (phosphocreatine system); supports muscle and possibly brain bioenergetics. | Very well-established for strength/power and lean mass; growing evidence for cognitive and mitochondrial support. Cheap, safe. 3–5 g/day. | Grade A |
Omega-3 (EPA/DHA) | Incorporates into membranes; anti-inflammatory; supports mitochondrial membrane integrity. | Robust cardiovascular and anti-inflammatory data; indirect mitochondrial benefit. 1–2 g/day combined EPA+DHA. | Grade A |
CoQ10 / Ubiquinol | Electron carrier in the transport chain; antioxidant. Declines with age and with statin use. | Clear benefit in genuine deficiency and statin users; benefit in healthy people is smaller. Reasonable, safe. 100–200 mg/day (ubiquinol better absorbed). | Grade B |
Magnesium | Cofactor for ATP (ATP is biologically active as Mg-ATP) and hundreds of enzymes. | Widespread mild deficiency; correcting it supports energy metabolism, sleep, and glucose control. Glycinate or malate, 200–400 mg/day. | Grade B |
NAD+ precursors (NMN, NR) | Raise cellular NAD+ to support sirtuins and mitochondrial maintenance. | Human trials reliably raise NAD+ and are well tolerated, but clinical benefits so far are modest and mixed. Promising, not proven. (NMN's US supplement status is contested — check current regulation.) | Grade C |
Acetyl-L-Carnitine | Shuttles fatty acids into mitochondria for oxidation; supports brain energetics. | Some benefit in older adults and specific neurological contexts; general healthy-population data limited. 500–1500 mg/day. | Grade C |
PQQ | Claimed to stimulate mitochondrial biogenesis via PGC-1α signalling. | Interesting preclinical and small human data; not yet convincing. Low-risk experiment. 10–20 mg/day. | Grade C |
Alpha-Lipoic Acid | Mitochondrial antioxidant and cofactor; supports glucose metabolism. | Modest evidence for metabolic and neuropathy outcomes; general anti-aging case is weak. 300–600 mg/day. | Grade C |
This is the most exciting frontier in mitochondrial science. Unlike broad supplements, these peptides act on mitochondrial pathways with real precision — and while a lot of the human research is still early, the mechanisms are compelling and the direction of travel is genuinely promising.
Mitochondrial peptides are a fast-moving research field. Most are still investigational rather than approved medicines, and are best used to complement solid training and nutrition rather than replace them. Quality and purity vary by source, so choose a supplier you trust and talk to a qualified clinician before starting anything new.
Leverage decreases as you go down. Most people never need to leave Tier 1 and 2 to see meaningful change.
Studies, reviews, and podcast episodes on mitochondrial biology and longevity — plain-English briefs with links to the original source.
Nothing on this page is a recommendation to use any compound. Many peptides and NAD+ products discussed are investigational research compounds, are not approved for anti-aging use, and may be regulated or prohibited (including by anti-doping agencies) depending on your jurisdiction and situation. Evidence grades reflect the general state of published human research and will change as new data arrive. Purity and dosing of research-grade compounds are unregulated and inconsistent. Talk to a qualified clinician before making any changes to your training, diet, supplements, or medications — especially if you have a medical condition or take prescription drugs.